In practical terms, they act as chemical messengers: they bind to receptors on cells, interact directly with proteins, or prompt the body to release a specific hormone, then let that hormone carry out the actual work
The simplified comparison is this: Semaglutide: GLP-1 receptor activity Tirzepatide: GIP and GLP-1 receptor activity Retatrutide: GIP, GLP-1, and glucagon receptor activity under clinical investigation More receptor activity does not automatically mean a medication is better for every patient
Liraglutide reduces CNS activation in response to visual food cues only after short-term treatment in patients with type 2 diabetes
2 Since it is non-peptide, orforglipron avoids GI degradation barriers that limit peptides, thereby enabling once-daily administration while maintaining efficacy on glucose control, body weight, and tolerability
Some practical considerations: Evening injection some patients prefer injecting in the evening so they can sleep through any initial side effects like nausea Consistency matters most choosing the same day and roughly the same time each week helps maintain stable drug levels Injection sites abdomen, thigh, or upper arm, with rotation between sites to reduce injection-site reactions What about non-standard intervals (every 5 days)
It simply means staying aware
